The table below shows OCULAR THERAPEUTIX, INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$204.88M
-$134.68M
-$70.23M
-$59.60M
-$65.55M
-$53.55M
Capital expenditure
$12.01M
$1.29M
$6.09M
$3.71M
$1.19M
$841.00K
Investing cash flow
-$11.88M
-$1.29M
-$6.09M
-$3.71M
-$1.19M
-$841.00K
Dividends paid
-
-
-
-
OCUL operating cash flow (10-K history)
OCULAR THERAPEUTIX, INC reported operating cash flow of -$204.88M for fiscal year 2025. That is down 52.1% from -$134.68M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$34.00M (FY 2016) to -$204.88M. Figures come from the company's audited annual reports as filed with the SEC.